Who Paid My Doc
Elana Koss
Cardiovascular Disease Roslyn, NY Medical Doctor
NPI 1376831339 CMS profile 544731
100 Port Washington Blvd., Cardiac Imaging, Roslyn, NY 11576
General payments
$120,990
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$2,506
Through program year 2025, Elana Koss of Roslyn, NY is reported in the CMS Open Payments database as having received $120,990 across 297 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $2,506 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 97th percentile of Cardiovascular Disease profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $34,345 | 48 | |
| 2024 | General | $26,868 | 46 | |
| 2023 | General | $46,340 | 78 | |
| 2022 | General | $6,622 | 46 | |
| 2021 | General | $2,824 | 37 | |
| 2020 | General | $2,148 | 20 | |
| 2019 | General | $1,843 | 22 |
Beside peers
- Elana Koss
- Cardiovascular Disease median
- Middle half of Cardiovascular Disease
- National median
In program year 2025, general payments to Elana Koss were reported at $34,345. Among 16,617 Cardiovascular Disease profiles paid that year, the median was $432 and the middle half received between $132 and $1,252.
Show as a table
| Year | Elana Koss | Cardiovascular Disease median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $1,843 | $450 | $127–$1,392 | $163 |
| 2020 | $2,148 | $242 | $77–$751 | $114 |
| 2021 | $2,824 | $335 | $101–$1,037 | $132 |
| 2022 | $6,622 | $395 | $121–$1,211 | $149 |
| 2023 | $46,340 | $443 | $136–$1,283 | $160 |
| 2024 | $26,868 | $450 | $136–$1,323 | $164 |
| 2025 | $34,345 | $432 | $132–$1,252 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 10 billing codesPaid by Medicare
$43,526
Medicare patients
386
Services billed
877
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Ischemic heart disease | 75% | |
| Heart failure | 66% | |
| Arthritis | 51% | |
| Atrial fibrillation | 50% | |
| Diabetes | 46% | |
| Chronic kidney disease | 39% | |
| COPD | 23% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
297 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Cardiovascular Disease in New York
Roger Hajjar
Cardiovascular Disease · New York, NY
Szilard Voros
Cardiovascular Disease · Stony Brook, NY
Gregg Stone
Cardiovascular Disease · New York, NY
Augustin Delago
Cardiovascular Disease · Albany, NY
Philippe Genereux
Cardiovascular Disease · New York, NY
Adam Rosenbluth
Cardiovascular Disease · New York, NY
Related records
Cardiovascular Disease in New York
Practitioners in the same specialty and state, ranked by reported value.
All Cardiovascular Disease
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.